CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes

被引:344
作者
Bos, Rinke [1 ]
Sherman, Linda A. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
INTRATUMORAL INJECTION; INTERLEUKIN-2; TOLERANCE; CHEMOKINE; IMMUNITY; MELANOMA; GAMMA; IMMUNOTHERAPY; EXPRESSION; EXPANSION;
D O I
10.1158/0008-5472.CAN-10-1322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CD4 help for CD8(+) T lymphocytes prevents tolerance and promotes the survival of effector and memory CD8(+) T cells. Here, we describe additional helper functions that require CD4(+) T cells within the tumor environment. CD8(+) T-cell recruitment, proliferation, and effector function within the tumor were greatly enhanced by tumor-specific CD4(+) T cells. Recruitment of CD8(+) T cells was accelerated by IFN-gamma-dependent production of chemokines. Production of interleukin-2 by tumor resident CD4(+) T cells enhanced CD8(+) T-cell proliferation and upregulated expression of granzyme B. These results highlight a novel role for tumor-specific CD4(+) T cells in promoting CD8(+) T-cell recruitment and cytolytic function, two previously unappreciated aspects of tumor-specific CD4 help. Cancer Res; 70(21); 8368-77. (C) 2010 AACR.
引用
收藏
页码:8368 / 8377
页数:10
相关论文
共 46 条
[1]   INTRATUMORAL INJECTION OF AN ADENOVIRUS EXPRESSING INTERLEUKIN-2 INDUCES REGRESSION AND IMMUNITY IN A MURINE BREAST-CANCER MODEL [J].
ADDISON, CL ;
BRACIAK, T ;
RALSTON, R ;
MULLER, WJ ;
GAULDIE, J ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8522-8526
[2]   ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE [J].
BATTEGAY, M ;
MOSKOPHIDIS, D ;
RAHEMTULLA, A ;
HENGARTNER, H ;
MAK, TW ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4700-4704
[3]   Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12 [J].
Bramson, JL ;
Hitt, M ;
Addison, CL ;
Muller, WJ ;
Gauldie, J ;
Graham, FL .
HUMAN GENE THERAPY, 1996, 7 (16) :1995-2002
[4]   Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy [J].
Buckanovich, Ronald J. ;
Facciabene, Andrea ;
Kim, Sarah ;
Benencia, Fabian ;
Sasaroli, Dimitra ;
Balint, Klara ;
Katsaros, Dionysios ;
O'Brien-Jenkins, Anne ;
Gimotty, Phyllis A. ;
Coukos, George .
NATURE MEDICINE, 2008, 14 (01) :28-36
[5]   Progressive loss of CD8(+) T cell-mediated control of a gamma-herpesvirus in the absence of CD4(+) T cells [J].
Cardin, RD ;
Brooks, JW ;
Sarawar, SR ;
Doherty, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :863-871
[6]   Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].
Cole, KE ;
Strick, CA ;
Paradis, TJ ;
Ogborne, KT ;
Loetscher, M ;
Gladue, RP ;
Lin, W ;
Boyd, JG ;
Moser, B ;
Wood, DE ;
Sahagan, BG ;
Neote, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021
[7]  
COUSENS LP, 1995, J IMMUNOL, V155, P5690
[8]   IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion [J].
D'Souza, WN ;
Lefrançois, L .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5727-5735
[9]  
Deeths MJ, 1999, J IMMUNOL, V163, P102
[10]   HUMIG - A NEW HUMAN MEMBER OF THE CHEMOKINE FAMILY OF CYTOKINES [J].
FARBER, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) :223-230